Takehiro Kato

9PUBLICATIONS
35CO-AUTHORS
Cancer cell biologyMolecular targetsCardiology (incl. cardiovascular diseases)Clinical pharmacy and pharmacy practicePharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 15, 2026
ChREBP drives β-cell proliferation under metabolic stress but not in pregnancy-induced β-cell expansion.

Sodai Kubota, Seiya Banno, Katsumi Iizuka

|Jul 26, 2024
Sporadic Parathyroid Carcinoma Treated With Lenvatinib, Exhibiting a Novel Somatic MEN1 Mutation.

Yu Ito, Toshinori Imaizumi, Hisashi Daido

|Nov 01, 2023
Erdheim-Chester Disease With BRAF V600E Mutation and Central Diabetes Insipidus Successfully Treated With Glucocorticoid.

Toshinori Imaizumi, Hisashi Daido, Takehiro Kato

|Jun 26, 2023
Effectiveness of countermeasure for polypharmacy by multidisciplinary team review in patients with diabetes mellitus.

Shohei Nishida, Takehiro Kato, Yuichi Hayashi

|Oct 25, 2022
Association of dipeptidyl peptidase-4 inhibitor use and risk of pancreatic cancer in individuals with diabetes in Japan.

Sodai Kubota, Takuya Haraguchi, Hitoshi Kuwata

|Sep 19, 2022
Semaglutide is effective in type 2 diabetes and obesity with schizophrenia.

Kaoru Noda, Takehiro Kato, Nao Nomura

Pageof 2

Frequent Collaborators

7 joint publications

Daisuke Yabe

4 joint publications

Sodai Kubota

4 joint publications

Yoshihiro Takahashi

3 joint publications

Toshinori Imaizumi